Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS

Clinical trial NCT03918304 · COMPLETED

Trial details

NCT number: NCT03918304
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2019-06-11
Primary completion: 2024-10-27
Enrollment: 923

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.